These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 18989228)
1. Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. Rebbapragada A; Howe K; Wachihi C; Pettengell C; Sunderji S; Huibner S; Ball TB; Plummer FA; Jaoko W; Kaul R J Acquir Immune Defic Syndr; 2008 Dec; 49(5):520-2. PubMed ID: 18989228 [TBL] [Abstract][Full Text] [Related]
2. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility. Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498 [TBL] [Abstract][Full Text] [Related]
3. Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study. Alcaide ML; Strbo N; Romero L; Jones DL; Rodriguez VJ; Arheart K; Martinez O; Bolivar H; Podack ER; Fischl MA PLoS One; 2016; 11(4):e0153045. PubMed ID: 27078021 [TBL] [Abstract][Full Text] [Related]
4. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity. Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200 [TBL] [Abstract][Full Text] [Related]
5. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection. Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228 [TBL] [Abstract][Full Text] [Related]
6. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection. Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260 [TBL] [Abstract][Full Text] [Related]
7. Bacterial vaginosis and the cervicovaginal immune response. Mitchell C; Marrazzo J Am J Reprod Immunol; 2014 Jun; 71(6):555-63. PubMed ID: 24832618 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection. Masson L; Arnold KB; Little F; Mlisana K; Lewis DA; Mkhize N; Gamieldien H; Ngcapu S; Johnson L; Lauffenburger DA; Abdool Karim Q; Abdool Karim SS; Passmore JA Sex Transm Infect; 2016 May; 92(3):186-93. PubMed ID: 26511781 [TBL] [Abstract][Full Text] [Related]
9. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines. Mitchell CM; Balkus J; Agnew KJ; Cohn S; Luque A; Lawler R; Coombs RW; Hitti JE AIDS Res Hum Retroviruses; 2008 May; 24(5):667-71. PubMed ID: 18462081 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the Genital Mucosa Immune Profile to Distinguish Phases of the Menstrual Cycle: Implications for HIV Susceptibility. Boily-Larouche G; Lajoie J; Dufault B; Omollo K; Cheruiyot J; Njoki J; Kowatsch M; Kimani M; Kimani J; Oyugi J; Fowke KR J Infect Dis; 2019 Feb; 219(6):856-866. PubMed ID: 30383238 [TBL] [Abstract][Full Text] [Related]
11. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age. Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129 [TBL] [Abstract][Full Text] [Related]
12. HIV-inducing factor in cervicovaginal secretions is associated with bacterial vaginosis in HIV-1-infected women. Cohn JA; Hashemi FB; Camarca M; Kong F; Xu J; Beckner SK; Kovacs AA; Reichelderfer PS; Spear GT J Acquir Immune Defic Syndr; 2005 Jul; 39(3):340-6. PubMed ID: 15980696 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1. Mauck C; Chen PL; Morrison CS; Fichorova RN; Kwok C; Chipato T; Salata RA; Doncel GF AIDS Res Hum Retroviruses; 2016 May; 32(5):443-51. PubMed ID: 26650885 [TBL] [Abstract][Full Text] [Related]
14. Cervicovaginal inflammatory cytokines and sphingomyelinase in women with and without bacterial vaginosis. Hemalatha R; Ramalaxmi BA; KrishnaSwetha G; Kumar PU; Rao DM; Balakrishna N; Annapurna V Am J Med Sci; 2012 Jul; 344(1):35-9. PubMed ID: 22157388 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility. McKinnon LR; Nyanga B; Chege D; Izulla P; Kimani M; Huibner S; Gelmon L; Block KE; Cicala C; Anzala AO; Arthos J; Kimani J; Kaul R J Immunol; 2011 Dec; 187(11):6032-42. PubMed ID: 22048765 [TBL] [Abstract][Full Text] [Related]
16. High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. Sturm-Ramirez K; Gaye-Diallo A; Eisen G; Mboup S; Kanki PJ J Infect Dis; 2000 Aug; 182(2):467-73. PubMed ID: 10915077 [TBL] [Abstract][Full Text] [Related]
17. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999 [TBL] [Abstract][Full Text] [Related]
18. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility. Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843 [TBL] [Abstract][Full Text] [Related]
19. Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark. Wessman M; Thorsteinsson K; Jensen JS; Storgaard M; Rönsholt FF; Johansen IS; Pedersen G; Nørregård Nielsen L; Bonde J; Katzenstein TL; Weis N; Lebech AM BMC Infect Dis; 2017 May; 17(1):376. PubMed ID: 28569142 [TBL] [Abstract][Full Text] [Related]
20. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study. Alcaide ML; Rodriguez VJ; Brown MR; Pallikkuth S; Arheart K; Martinez O; Roach M; Fichorova RN; Jones DL; Pahwa S; Fischl MA AIDS Res Hum Retroviruses; 2017 Apr; 33(4):309-317. PubMed ID: 27897054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]